Cross-Border M&A is followed by cross-border investor relations

Arsia Amir-Aslani is Program Director is at the Department of Management and Technology, Grenoble Ecole de Management, Grenoble, France. He is Program Director of the Advanced Master’s degree “Biotechnology and Pharmaceutical Management” at Grenoble Ecole de Management. He is former Investment Banker and was a senior marketing executive at a health-care consultancy firm, where he provided consulting services to leading Health care companies. He has more than 18 years of experience in the Hi-technology and Biotechnology sectors from a capital market, consulting, educational and industry perspective. He holds PhD in Biochemical Sciences from the University of Paris, Pierre et Marie-Curie, as well as a MSc in International Management from the University of Paris, Sorbonne. Furthermore, since 2009, he has been Professor of Strategy and Finance at Grenoble Ecole de Management. He has numerous publications in both academic and practitioner journals.

Philippe Lê is Associate Professor is at the Department of Management and Technology, Grenoble Ecole de Management, Grenoble, France. He is Program Director of the Advanced Master’s degree in “Innovation & Technology Management”. Prior to joining GEM, he has been on the faculty of the University of Angers and Pau Business School in France. Moreover, he has been a visiting lecturer and guest speaker in strategy and innovation in Switzerland (HEC, University of Geneva), England (Aston Business School, Birmingham), Russia (Ural State University) and Germany (Humboldt-University of Berlin). Professor Lê has published a book in French on management of technology and innovation entitled “Piloter et réussir l’innovation en entreprise: aider l’entrepreneur à être stratège”. In addition, he has written general-interest articles for several leading specialized magazines and financial newspapers. His work centers on strategy/business model innovation, on the appropriate strategic response to corporate challenges, be they social, technological or regulatory and on the sources of companies’ long-term profitability. Furthermore, since 2001, Dr Lê has been Professor of Strategy at Grenoble Ecole de Management. He holds PhD from the University of Aix-Marseille (Institut d’Administration des Entreprises)-ESSEC.

Mark Anthony Chanel is Affiliate Professor of Strategy and Finance at Department of Strategy and Finance, Grenoble Ecole de Management, Grenoble, France. He has more than 15 years of professional work experience in health care and technology companies. He is currently working as a consultant helping small and midsized companies while also teaching at several universities. Most recently Mark was the Director, Finance and Administration for a company focused on the pharmaceutical market in the USA, and was also a Director in a medical device company that went through a successful initial public offering on the NASDAQ stock exchange. Mark’s areas of expertise include Finance, Human Resources, Operations, and Competitive Intelligence. He holds a BSE degree in Chemical Engineering, an MSc degree in Management Consulting, and an MBA degree in Finance. In addition, he has authored several papers dealing with Finance and Competitive Intelligence.